Innate Immunotherapeutics

Manufacturing · Australia · 1-10 Employees

View Company Info for Free

Overview

Headquarters

35 Lime St Ste 401, Sydney, New South Wa...

Phone Number

+61 280033650

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About Innate Immunotherapeutics

Innate Immunotherapeutics Limited is a medical biotechnology company with offices in Sydney (Australia) and Auckland (New Zealand). The Company has designed and manufactured a unique immunomodulator microparticle technology. This technology can be used to induce the human immune system to fight certain cancers and infections, or modulate certain immune mechanisms implicated in autoimmune diseases such as Multiple Sclerosis. The same technology can be used in the design of better vaccines to potentially treat or prevent diseases such as influenza, cancer, malaria, or tuberculosis. The microparticle at the core of this technology provides a unique delivery system for a suite of both known and novel immune system triggers or modulators. By attaching selected modulators to the microparticle, these triggers can be delivered reliably to specific cells of the immune system. Target diseases or applications for drugs developed using this approach include: Auto-immune diseases such as Multiple SRead more
Innate Immunotherapeutics's Social MediaPopular SearchesInnate Immunotherapeutics LtdInnate ImmunotherapeuticsAmplia Therapeutics? ToInnate Immunotherapeutics - LtdInnate Immunotherapeutics LtSIC Code 28,283NAICS Code 32,325Show more

Innate Immunotherapeutics Org Chart

PhoneEmail
MR
Australia flag for contact location.

Manager, Quality Assurance

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
CM
Australia flag for contact location.

Senior Research Scientist

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Innate Immunotherapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Innate Immunotherapeutics

Compare insights from companies similar to Innate Immunotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Innate Immunotherapeutics

<$5M
1-10
Private
-
2000
MR
Margaret RhoadesManager, Quality Assurance
$71.9M
1-10
Public
$18.2M
2012
LC
Leslie ChongCEO & Managing Director
$5.2M
11-50
Private
$18M
2014
Himanshu Brahmbhatt, Joint-CEO and Director at Engeneic
Himanshu BrahmbhattJoint-CEO and Director
$5.1M
11-50
Public
$14M
2014
Abby Macnish Niven, Chief Financial Officer & Company Secretary at Paradigm Biopharmaceuticals
Abby Macnish NivenChief Financial Officer & Company Secretary
<$5M
11-50
Private
-
-
N/A
11-50
Public
$140M
2001
DM
Deanne MillerChief Operating Officer
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Innate Immunotherapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Innate Immunotherapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Innate Immunotherapeutics.

Innate Immunotherapeutics Tech Stack

A closer look at the technologies used by Innate Immunotherapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Innate Immunotherapeutics

What is Innate Immunotherapeutics's official website?
Innate Immunotherapeutics's official website is www.innateimmunotherapeutics.com
What is Innate Immunotherapeutics's Revenue?
Innate Immunotherapeutics's revenue is <$5 Million
What is Innate Immunotherapeutics's SIC code?
Innate Immunotherapeutics's SIC: 28,283
What is Innate Immunotherapeutics's NAICS code?
Innate Immunotherapeutics's NAICS: 32,325
How many employees does Innate Immunotherapeutics have?
Innate Immunotherapeutics has 1-10 employees
What industry does Innate Immunotherapeutics belong to?
Innate Immunotherapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Innate Immunotherapeutics competition?
Innate Immunotherapeutics top competitors include: Active Biochemku, Immutep, Neuren Pharmaceuticals, Engeneic
What technology does Innate Immunotherapeutics use?
Some of the popular technologies that Innate Immunotherapeutics uses are: reCAPTCHA, Google Font API, Font Awesome, Amazon Web Hosting
How do I contact Innate Immunotherapeutics?
Innate Immunotherapeutics contact info: Phone number: +61 280033650 Website: www.innateimmunotherapeutics.com
What does Innate Immunotherapeutics do?

Innate Immunotherapeutics Limited is a medical biotechnology company with offices in Sydney (Australia) and Auckland (New Zealand). The Company has designed and manufactured a unique immunomodulator microparticle technology. This technology can be used to induce the human immune system to fight certain cancers and infections, or modulate certain im... mune mechanisms implicated in autoimmune diseases such as Multiple Sclerosis. The same technology can be used in the design of better vaccines to potentially treat or prevent diseases such as influenza, cancer, malaria, or tuberculosis. The microparticle at the core of this technology provides a unique delivery system for a suite of both known and novel immune system triggers or modulators. By attaching selected modulators to the microparticle, these triggers can be delivered reliably to specific cells of the immune system. Target diseases or applications for drugs developed using this approach include: Auto-immune diseases such as Multiple Sclerosis; Certain cancers that are known to be immune-sensitive, such as prostate, colon, & renal cancer; and Preventive vaccines for malaria and tuberculosis, and therapeutics vaccines for cancers. The first drug candidate developed using this technology, MIS416, combines two well described immunostimulatory ligands or triggers - NOD2 & TLR9. MIS416, has demonstrated safety and efficacy in a number of different disease or injury models. Due to the significant degree of unmet medical need, Secondary Progressive Multiple Sclerosis has been selected as the initial clinical target for MIS416. A Phase 1B human study in patients with primary progressive or secondary progressive MS (SPMS) was completed in October 2011 and a follow on 'dose confirmation' Phase 2A study in patients with secondary progressive MS was completed in July 2012. The results from these studies met or exceeded expectations and the Company is now conducting a larger-longer Phase 2B trial in patients with SPMS. This study commenced in Australia in late 2014.Read More

What are Innate Immunotherapeutics social media links?
Innate Immunotherapeutics Linkedin page Innate Immunotherapeutics Twitter page
Is Innate Immunotherapeutics a public company?
Innate Immunotherapeutics is private company therefore does not currently have an official ticker symbol
See more information about Innate Immunotherapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.